Drug resistant stem cells may be source of genetic chaos, DNA damage, in leukemia

An international team of scientists, led by researchers from Temple University School of Medicine, has found that a source of mounting genomic chaos, or instability, common to chronic myeloid leukemia (CML) may lie in a pool of leukemia stem cells that are immune to treatment with potent targeted anticancer drugs. Findings were presented at the 54th American Society of Hematology Annual Meeting and Exposition in Atlanta. Read more here.